The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening

International Journal of Obesity

Volumn 24, Issue , 2000, Pages S6-S11

  Lauritzen, T ^a   Griffin, S ^b   Borch Johnsen, K ^c   Wareham, N J ^b   Wolffenbuttel, B H R ^d   Rutten, G ^e  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c STENO DIABETES CENTER   (Denmark)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Family practice; Intensive; Multifactorial intervention; Randomised controlled trial; Screening; Type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIGUANIDE DERIVATIVE; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLICLAZIDE; GLUCOSE; ISOPHANE INSULIN; LOOP DIURETIC AGENT; METFORMIN; METOPROLOL; REPAGLINIDE; SULFONYLUREA DERIVATIVE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DENMARK; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEALTH CARE COST; HEALTH STATUS; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; MASS SCREENING; MORBIDITY; MORTALITY; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT SATISFACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; BLOOD GLUCOSE; COST-BENEFIT ANALYSIS; DENMARK; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; HUMANS; HYPERGLYCEMIA; INTERVENTION STUDIES; MALE; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDIES; NETHERLANDS; PRACTICE GUIDELINES; PREVALENCE; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; VASCULAR DISEASES;

EID: 0033808127     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0801420     Document Type: Article

References (47)

1. Wilson JGM, Jungner G. Principles and practice of screening for disease. World Health Organization, Geneva: 1968.
2. Engelgau MM, Aubert RE, Thompson TJ, Herman WH. Screening for NIDDM in nonpregnant adults: a review of principles, screening tests, and recommendations. Diabetes Care 1995; 18: 1606-1617.
3. National Screening Committee. First Report of the National Screening Committee. Health Departments of the United Kingdom: London, 1998.
4. McCarty D, Zimmet P. Diabetes 1994 to 2010: global estimates and projections. International Diabetes Institute: Melbourne, 1994.
5. Neil HAW, Mather HM, Thompson QV, Thorogood GH, Fowler GH, Hill RD. The Oxford Community Diabetes Study: evidence for an increase in the prevalence of known diabetes in Great Britain. Diabetic Med 1987; 4: 539-543.
6. King’s Fund Policy Institute. Counting the cost: the real impact of non-insulin-dependent diabetes mellitus. British Diabetic Association: London, 1997.
7. Jackson DMA, Wills R, Davies J, Meadows K, Singh BM Wise PH. Public awareness of the symptoms of diabetes mellitus. Diabetic Med 1991; 8: 971-972.
8. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993; 16: 642-652.
9. Kuo HS, Chang HJ, Chou P, Teng L, Chen TH. A Markov chain model to assess the efficacy of screening for non-insulin dependent diabetes mellitus (NIDDM). Int J Epidemiol 1999; 28: 233-240.
10. Harris MI, Klein R, Wellborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 y before clinical diagnosis. Diabetes Care 1992; 15: 815-819.
11. Thompson TJ, Engelgau MM, Hegazy M, Ali MA, Sous ES, Badran A, Herman WH. The onset of NIDDM and its relationship to clinical diagnosis in Egyptian adults. Diabetic Med 1996; 13: 337-340.
12. UK Prospective Diabetes Study Group. UK prospective diabetes study 6. Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Research 1990; 13: 1-11.
13. UK Prospective Diabetes Study Group. UKPDS VIII. Study design, progress and performance. Diabetologia 1991; 34: 877-890.
14. Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 1990; 263: 2893-2898.
15. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with Type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
16. Guillausseau P-J, Massin P, Charles M-A, Allaguy H, Guvenli Z, Virally M, Tielmans D, Assayag M, Warnet A, Lubetzki J. Glycaemic control and development of retinopathy in Type 2 diabetes mellitus: a longitudinal study. Diabetic Med 1998; 15: 151-155.
17. Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A meta-regression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 y. Diabetes Care 1999; 22: 233-240.
18. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Schichiri M. Intensive insulin therapy prevents the progression of diabetic microvas-cular complications in Japanese patients with non-insulindependent diabetes mellitus: a randomized prospective 6-y study. Diabetes Res Clin Pract 1995; 28: 103-117.
19. Kinmonth AL, Griffin S, Wareham NJ. Implications of the United Kingdom Prospective Diabetes Study for general practice care of Type 2 diabetes. Br J Gen Pract 1999; 49: 692-694.
20. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. Br Med J 1998; 317: 703-713.
21. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with Type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet 1999; 353: 617-622.
22. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvas-cular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000; 355: 253-259.
23. Davies MJ, Grenfell A, Day JL. Clinical characteristics and follow-up of subjects with non-insulin-dependent diabetes mellitus diagnosed by screening. Practical Diabetes International 1996; 13: 75-78.
24. Pyorala K, Pedersen TR, Kjekshus J, Faergeman O, Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 1997; 20: 614-620.
25. van Drenth BB, Hulscher MEJL, van der Wouden JC, Mok-kink HGA, van Weel C, Grol RPTM. Relationship between practice organization and cardiovascular risk factor recording in general practice. Br J Gen Pract 1998; 48: 1054-1058.
26. Harris MI, Modan M. Screening for NIDDM. Why is there no national program? Diabetes Care 1994; 17: 440-444.
27. CDC Diabetes Cost-Effectiveness Study Group. The cost-effectiveness of screening for Type 2 diabetes. JAMA 1998; 280: 1757-1763.
28. Goyder E, Irwig L. Screening for diabetes: what are we really doing? Br Med J 1998; 317: 1644-1646.
29. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
30. Wonderling D, Langham S, Buxton M, Normand C, McDermott C. What can be concluded from the Oxcheck and British family heart studies: commentary on cost effectiveness analyses. Br Med J 1996; 312: 1274-1278.
31. Mallion JM, Dutry-Dupagne C, Vaur L, Genes N, Renault M, Elkik F, Baguet P, Boutelaut S. Benefits of electronic pillboxes in evaluating treatment compliance of patients with mild to moderate hypertension. J Hypertens 1996; 14: 137-144.
32. Ajzen I. The theory of planned behavior. Organizational Behavior and Human Decision Processes 1991; 50: 179-211.
33. Sutton S. Predictingandexplainingintentions andbehaviour: how well are we doing? JAppl Soc Psychol 1998; 28: 1317-1338.
34. Gollwitzer PM, Brandstatter V. Implementation intentions and effective goal pursuit. Journal of Personality and Social Psychology 1997; 73: 186-199.
35. Rollnick S, Kinnersley P, Stott N. Methods of helping patients with behaviour change. Br Med J 1993; 307: 188-190.
36. Kinmonth AL, Woodcock A, Griffin S, Spiegal N, Campbell MJ. Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. Br Med J 1998; 317: 1202-1208.
37. Stott NCH, Rollnick S, Pill RM. Innovation in clinical method: diabetes care and negotiating skills. Fam Pract 1995; 12: 413-418.
38. Khunti K, Baker R, Rumsey M, Lakhani M. Quality of care of patients with diabetes: collation of data from multi-practice audits of diabetes in primary care. Fam Pract 1999; 16: 54-59.
39. Griffin S. Diabetes care in general practice: meta-analysis of randomised control trials. Br Med J 1998; 317: 390-396.
40. Rutten GEHM, van Eijk JTM, De Nobel E, Beek MML, van der Velden H. Feasibility and effects of a diabetes Type II protocol with blood glucose self-monitoring in general practice. Fam Pract 1990; 7: 273-278.
41. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetesriskscore:towardsearlier detection ofType2diabetes in general practice. Diabetes Metab Res Rev 2000; 16: 164-171.
42. Voss EM, Cembrowski GS. Performance characteristics of the HemoCue B-Glucose analyzer using whole-blood samples. Arch Pathol Lab Med 1993; 117: 711-713.
43. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Med 1998; 15: 539-553.
44. Diabetes Services Advisory Committee of the British Diabetic Association. Recommendations for the management of diabetes in primary care. British Diabetic Association: London, 1993.
45. Ikke-insulinkrœvende diabetes-NIDDM. En praktisk vejkedn-ing for behandlere. Dansk Selskab for Almen Medicin, 1998.
46. Forebyggelse af iskœmisk hjertesygdom i almen praksis-sœrlig med henblik pa dyslipidoemi. Klinisk vejledning, Dansk Selskab for Almen Medicin, 1999.
47. Guidelines on Diabetes Mellitus Type 2, Dutch College of General Practitioners. Huisarts Wet 1999; 42: 67-84.